Ontogeny of dextromethorphan O- and N-demethylation in the first year of life (Q34575597)

3 August 2017

title

Ontogeny of dextromethorphan O- and N-demethylation in the first year of life (English)

1 reference

3 August 2017

7

James LP

1 reference

3 August 2017

9

Kearns GL

1 reference

3 August 2017

Blake MJ

1

1 reference

3 August 2017

Gaedigk A

2

1 reference

3 August 2017

Pearce RE

3

1 reference

3 August 2017

Bomgaars LR

4

1 reference

3 August 2017

Christensen ML

5

1 reference

3 August 2017

Stowe C

6

1 reference

3 August 2017

Wilson JT

8

1 reference

3 August 2017

Leeder JS

10

1 reference

3 August 2017

language of work or name

English

0 references

publication date

14 February 2007

1 reference

Clinical Pharmacology & Therapeutics

3 August 2017

published in

1 reference

3 August 2017

volume

81

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

510-516

1 reference

Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Developmental pharmacology--drug disposition, action, and therapy in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

57 varieties: the human cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Expression of CYP2D6 in developing human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Developmental expression of the major human hepatic CYP3A enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Variability of CYP3A7 expression in human fetal liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Evaluation of dextromethorphan N-demethylation activity as a biomarker for cytochrome P450 3A activity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

The human intestinal cytochrome P450 "pie".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D642, in African American subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

Cytochrome P450 3A: ontogeny and drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Investigation of terbinafine as a CYP2D6 inhibitor in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Omission of the deconjugation step in urine analysis and the unaltered outcome of CYP2D6 phenotyping with dextromethorphan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Enzymes in addition to CYP3A4 and 3A5 mediate N-demethylation of dextromethorphan in human liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Potential fluoxetine chloride (Prozac) toxicity in a newborn

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Neonatal paroxetine withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100101

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100101

1 reference

Dimensions Publication ID

3 August 2017

1040229074

0 references

1 reference